The First Nations Molecular Point-of-Care Testing Program has been awarded the Excellence in Indigenous Engagement Award at the 2026 Engagement Australia Excellence Awards, recognising more than a decade of partnership-driven work to expand access to testing and improve health outcomes for First Nations communities across Australia.
The program is coordinated by the Kirby Institute and Flinders University's International Centre for Point-of-Care Testing, in partnership with Aboriginal medical services, Aboriginal Community Controlled Health Organisations, government agencies, laboratories and other stakeholders. The Program is funded by the Australian Centre for Disease Control (CDC).
The Engagement Australia Excellence Awards focus on outstanding nation-building initiatives, demonstrating far-reaching impact and innovation, in all sectors and aspects of the Australian economy and community.
The First Nations Molecular Point-of-Care Testing Program was awarded the Excellence in Indigenous Engagement award, which recognises "outstanding collaborations between tertiary education and Indigenous communities in Australia, New Zealand and beyond that empowers and give voice to First Nations peoples."
Kim Gates, Community Relations Lead for the First Nations Molecular Point-of-Care Testing Program and Stacey Foster-Rampant, the Program’s jurisdiction coordinator, accepted the award on behalf of the Program. Kim spoke about the impact of the partnership model central to the program's success.
"The success and growth of the program reflects the commitment and leadership of Aboriginal medical services, Aboriginal Community Controlled Health Organisations, government agencies, laboratories and other stakeholders who have partnered with the Kirby Institute and Flinders University's International Centre for Point-of-Care Testing over more than a decade," said Ms Gates.
"We share this recognition with everyone who has contributed their knowledge, trust and support along the way. We are incredibly proud to work alongside people who continue to drive better health outcomes in ways that are locally led and responsive to community needs." said Ms Gates.
The program began in 2011 as a trial called Test Treat and Go (TTANGO), which tested the acceptability and effectiveness of innovative molecular point-of-care testing technology for sexually transmitted infections in 11 remote primary health care clinics. Following the success of the trial, funding was secured to sustain and expand the model, bringing molecular point-of-care testing to more than 80 clinics, including some of the most remote communities in Australia, and broadening its scope to include a wider range of infectious diseases.
The award recognises the collective efforts of the many organisations, communities and individuals that have shaped the program's development over more than a decade, in particular the nurses, Aboriginal health practitioners and health workers who deliver testing in their communities every day and whose work is central to the program’s success.